CYTORI THERAPEUTICS INC - COM NEW (CYTX)

CUSIP: 23283K204

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
2,820,904
Share change
+121,459
Total reported value
$4,511,213
Put/Call ratio
69%
Price per share
$1.60
Number of holders
25
Value change
+$195,567
Number of buys
14
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 23283K204?
CUSIP 23283K204 identifies CYTX - CYTORI THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM NEW (CYTX) as of Q1 2017

As of 31 Mar 2017, CYTORI THERAPEUTICS INC - COM NEW (CYTX) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,820,904 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, BlackRock Inc., Creative Planning, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, JACOBS LEVY EQUITY MANAGEMENT, INC, KCG HOLDINGS, INC., and RENAISSANCE TECHNOLOGIES LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.